Drug, medtech companies fear GST changes may squeeze funds

Drug, medtech companies fear GST changes may squeeze funds

New Delhi: The pharmaceutical and medtech industries are worried about the impending Goods and Services Tax (GST) reforms as they expect the step to impact operating costs and working capital, straining their financial health. Rajiv Nath, forum coordinator, The Association of Indian Medical Device Industry (AiMeD) said for equipment, electronics, reagents, and implants, reducing GST…

Read More